BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15231134)

  • 1. [Relationship between alterations of p16INK4a and p14ARF genes of CDKN2A locus and gastric carcinogenesis].
    Tang SH; Yang DH; Luo HS; Yu JP; Shu JC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):517-21. PubMed ID: 15231134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis.
    Tang S; Luo H; Yu J; Yang D; Shu J
    Chin Med J (Engl); 2003 Jul; 116(7):1083-7. PubMed ID: 12890389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer.
    Lee M; Sup Han W; Kyoung Kim O; Hee Sung S; Sun Cho M; Lee SN; Koo H
    Pathol Res Pract; 2006; 202(6):415-24. PubMed ID: 16675157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of p14ARF and p16INK4a genes in salivary gland carcinomas.
    Nishimine M; Nakamura M; Kishi M; Okamoto M; Shimada K; Ishida E; Kirita T; Konishi N
    Oncol Rep; 2003; 10(3):555-60. PubMed ID: 12684623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma.
    Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS
    Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type.
    Tsujimoto H; Hagiwara A; Sugihara H; Hattori T; Yamagishi H
    Pathol Res Pract; 2002; 198(12):785-94. PubMed ID: 12608655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
    Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
    Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms.
    Silva J; Silva JM; Domínguez G; García JM; Cantos B; Rodríguez R; Larrondo FJ; Provencio M; España P; Bonilla F
    J Pathol; 2003 Mar; 199(3):289-97. PubMed ID: 12579530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma.
    Fukai K; Yokosuka O; Imazeki F; Tada M; Mikata R; Miyazaki M; Ochiai T; Saisho H
    Liver Int; 2005 Dec; 25(6):1209-16. PubMed ID: 16343074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
    Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
    Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia.
    Kresty LA; Mallery SR; Knobloch TJ; Li J; Lloyd M; Casto BC; Weghorst CM
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3179-87. PubMed ID: 18990760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers.
    Pacifico A; Goldberg LH; Peris K; Chimenti S; Leone G; Ananthaswamy HN
    Br J Dermatol; 2008 Feb; 158(2):291-7. PubMed ID: 18070208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.
    Perrone F; Tamborini E; Dagrada GP; Colombo F; Bonadiman L; Albertini V; Lagonigro MS; Gabanti E; Caramuta S; Greco A; Torre GD; Gronchi A; Pierotti MA; Pilotti S
    Cancer; 2005 Jul; 104(1):159-69. PubMed ID: 15929122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.
    Kiss NB; Geli J; Lundberg F; Avci C; Velazquez-Fernandez D; Hashemi J; Weber G; Höög A; Ekström TJ; Bäckdahl M; Larsson C
    Endocr Relat Cancer; 2008 Jun; 15(2):609-21. PubMed ID: 18509008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent methylation of p16INK4A/p14ARF promoters in tumorigenesis of Epstein-Barr virus transformed lymphoblastoid cell lines.
    Nagy E; Veress G; Szarka K; Csoma E; Beck Z
    Anticancer Res; 2005; 25(3B):2153-60. PubMed ID: 16158958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
    Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
    Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.